苏试试验(300416) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 reached ¥461,052,405.39, representing a 20.68% increase year-over-year[7] - Net profit attributable to shareholders for Q3 2022 was ¥72,487,323.05, a 45.13% increase compared to the same period last year[7] - The net profit after deducting non-recurring gains and losses was ¥66,163,410.84, up 47.38% year-over-year[7] - The company reported a basic earnings per share of ¥0.1960 for Q3 2022, which is a 45.14% increase year-over-year[7] - The company reported a 35.95% increase in net profit attributable to shareholders for the year-to-date period, totaling ¥178,718,924.34, driven by growth in environmental and reliability testing services[14] - Net profit rose to ¥205,560,651.59, compared to ¥151,279,298.81 in the previous period, marking an increase of approximately 36%[51] - The total profit amounted to ¥233,116,740.30, up from ¥175,474,401.76, reflecting a growth of around 32.9%[51] - Basic and diluted earnings per share were both ¥0.4831, compared to ¥0.3554 in the same period last year, indicating an increase of approximately 36%[54] Assets and Liabilities - The total assets at the end of Q3 2022 amounted to ¥3,978,849,770.69, reflecting a 5.50% increase from the end of the previous year[7] - The company's equity attributable to shareholders rose to ¥1,876,703,690.66, an increase of 9.5% from ¥1,713,444,454.91 year-over-year[46] - The total liabilities amounted to ¥1,927,496,604.23, slightly up from ¥1,922,040,675.99 in the previous year[46] - Non-current assets totaled ¥1,607,792,591.76, reflecting a growth of 3.9% compared to ¥1,554,374,637.04 in the previous year[43] - Total assets reached ¥3,978,849,770.69, up 5.5% from ¥3,771,306,061.50 year-over-year[43] Cash Flow - The cash flow from operating activities for the year-to-date period reached ¥114,613,297.78, showing a 50.88% increase compared to the same period last year[7] - Operating cash inflow totaled ¥1,164,238,402.17, slightly up from ¥1,149,669,865.34, showing a growth of about 1.3%[55] - Net cash flow from operating activities was $114.61 million, an increase from $75.96 million year-over-year[58] - Total cash outflow from operating activities amounted to $1.05 billion, slightly down from $1.07 billion in the previous year[58] - Cash inflow from financing activities totaled $494.87 million, a decrease from $503.01 million year-over-year[58] - The ending balance of cash and cash equivalents was $796.33 million, up from $312.55 million year-over-year[58] Shareholder Information - The total number of common shareholders at the end of the reporting period is 9,076[15] - The largest shareholder, Suzhou Testing Instrument General Factory, holds 35.71% of shares, totaling 132,124,200 shares[15] - The second-largest shareholder, China Merchants Bank Co., Ltd. - Penghua New Industry Mixed Securities Investment Fund, holds 2.05% of shares, totaling 7,575,681 shares[18] - The company has a total of 10 major shareholders, with the smallest holding 0.74% of shares, totaling 2,741,600 shares[18] - The report indicates that there are no related party relationships among the top 10 shareholders[18] Operational Metrics - The company experienced a 45.93% increase in accounts receivable, totaling ¥838,923,153.98, due to revenue growth and delayed collections[11] - Inventory increased to ¥443,609,020.90, a rise of 25.7% from ¥353,024,923.73 year-over-year[43] - Accounts receivable increased to ¥838,923,153.98 from ¥574,865,610.76, indicating a significant rise in outstanding payments[40] - The company reported a decrease in prepayments to ¥116,578,855.42 from ¥100,327,476.07[40] Investment and R&D - The company invested significantly in laboratory construction, with construction in progress increasing by 51.85% to ¥203,564,346.06[11] - R&D expenses increased to ¥91,480,338.88 from ¥74,200,893.12, representing a growth of approximately 23.3% year-over-year[51] Future Outlook - The report does not indicate any new strategies or market expansions for the upcoming period[27] - Future outlook includes plans for market expansion and potential new product development initiatives[48]